These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat. Bhargava HN, Kim HS. J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229 [Abstract] [Full Text] [Related]
5. beta-Endorphin: central sites of analgesia, catalepsy and body temperature changes in rats. Tseng LF, Wei ET, Loh HH, Li CH. J Pharmacol Exp Ther; 1980 Aug; 214(2):328-32. PubMed ID: 6248633 [Abstract] [Full Text] [Related]
6. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly). Bhargava HN, Walter R, Ritzmann RF. Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769 [Abstract] [Full Text] [Related]
7. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat. Bhargava HN, Kim HS. Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692 [Abstract] [Full Text] [Related]
9. Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse. Bhargava HN. Neuropharmacology; 1982 Mar; 21(3):227-33. PubMed ID: 6122186 [Abstract] [Full Text] [Related]
10. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol. Szabó G, Kovács GL, Székeli S, Baláspiri L, Telegdy G. Acta Physiol Hung; 1987 Mar; 69(1):115-22. PubMed ID: 2884803 [Abstract] [Full Text] [Related]
11. Skeletal muscle thermogenesis: its role in the hyperthermia of conscious rats given morphine or beta-endorphin. Powell-Jones K, Saunders WS, St Onge RD, Thornill JA. J Pharmacol Exp Ther; 1987 Oct; 243(1):322-32. PubMed ID: 2959769 [Abstract] [Full Text] [Related]
12. Effect of cyclo(Leu-Gly) on cyclic GMP-phosphodiesterase activity changes associated with development of tolerance to morphine-induced antinociception, catalepsy, respiratory depression and mydriasis. Burton CK, Ho IK, Hoskins B. J Pharmacol Exp Ther; 1991 Sep; 258(3):871-6. PubMed ID: 1653844 [Abstract] [Full Text] [Related]
14. Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat. Bhargava HN, Ramarao P. Peptides; 1989 Sep; 10(4):767-71. PubMed ID: 2573893 [Abstract] [Full Text] [Related]
15. The effects of peptides on tolerance to the cataleptic and hypothermic effects of morphine in the rat. Bhargava HN. Neuropharmacology; 1981 Apr; 20(4):385-90. PubMed ID: 6117032 [No Abstract] [Full Text] [Related]
16. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats. Bhargava HN. Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116 [Abstract] [Full Text] [Related]
17. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system. Yehuda S, Carasso RL. Peptides; 1982 Apr; 3(2):105-10. PubMed ID: 6124951 [Abstract] [Full Text] [Related]
18. Embryotoxicity of L-prolyl-L-leucyl-glycinamide, cyclo(1-amino-cyclopentanecarbonyl-alanyl) and cyclo(glycyl-leucyl), new potential neuropeptides in chick embryos. Kosar K, Vanzura J. Pharmazie; 1988 Oct; 43(10):715-6. PubMed ID: 2905482 [Abstract] [Full Text] [Related]
19. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors. Bhargava HN, Pandey RN, Matwyshyn GA. Life Sci; 1983 May 02; 32(18):2096-101. PubMed ID: 6133201 [Abstract] [Full Text] [Related]
20. The use of striatal dopaminergic supersensitivity for the evaluation of drugs with possible antidyskinetic properties. Valchár M, Krejcí I, Kasafírek E, Schuh J, Dlabac A. Pol J Pharmacol Pharm; 1985 May 02; 37(3):311-5. PubMed ID: 2866500 [Abstract] [Full Text] [Related] Page: [Next] [New Search]